Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate
George A. Díaz(Icahn School of Medicine at Mount Sinai), Brendan Lee(Baylor College of Medicine), Cary O. Harding(Oregon Health & Science University), Lawrence Merritt(Seattle Children's Hospital), Klara Dickinson, Dion F. Coakley, Stephen A. Bart, William Berquist(Palo Alto University), Mark Korson(Tufts Medical Center), Joseph Mauney, Wendy E. Smith(Maine Medical Center), Sandesh C. Sreenath Nagamani(Baylor College of Medicine), Bruce F. Scharschmidt, Cynthia LeMons(National Urea Cycle Disorders Foundation), Tristen Moors, Masoud Mokhtarani, Dennis Bartholomew(Nationwide Children's Hospital), Lauren Krivitzky(Children's Hospital of Philadelphia), Uta Lichter‐Konecki(Children's National), Nicola Longo(University of Utah), Annette Feigenbaum(Hospital for Sick Children), Shawn E. McCandless(University Hospitals of Cleveland), Roberto Zori(University of Florida), David Kronn(Westchester Medical Center), James Bartley(MemorialCare Long Beach Medical Center), Renata C. Gallagher(Children's Hospital Colorado), Susan A. Berry(University of Minnesota), Stephen Cederbaum(University of California, Los Angeles), William J. Rhead(Medical College of Wisconsin)
Cited by 95
Related Papers
Cockayne syndrome: Review of 140 cases
|American Journal of Medical Genetics|1992|807
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
|Genetics in Medicine|2014|718
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle Disorders
|New England Journal of Medicine|2007|355
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
|Genetics in Medicine|2009|292